(Reuters) — Edwards Lifesciences (NYSE:EW) yesterday raised its full-year profit forecast, citing strong demand for its transcatheter aortic valve implants. Irvine, Calif.-based Edwards reported 2nd-quarter earnings that exceeded Wall Street’s expectations, saying it benefited from significant growth in procedures using its TAVI devices, which are threaded through the arteries to the heart from a small incision. […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Essential Medical launches Manta device trial
Essential Medical said today it launched a clinical study of its Manta large bore vascular closure device. The Manta system is designed to close large bore punctures following procedures like transcatheter aortic valve replacements, abdominal aortic aneurysm repairs and balloon aortic valvuplasty, the Malvern, Penn.-based company said. Essential Medical said the device is designed to […]
Bellerophon plunges on failed cardiac implant trial
Bellerophon Therapeutics (NSDQ:BLPH) said today that its bioabsorbable cardiac matrix failed to meet both the primary and secondary endpoints in a 303-patient clinical trial, sending its share price down nearly -63% today. BCM is a liquid medical device injected into the coronary artery leading to the damaged area of a heart, and is designed for use after […]
Italian state attorney moves to block Sorin merger with Cyberonics
An Italian state attorney in Milan moved to block the pending, $2.7 billion merger between Sorin Group (BIT:SRN) and Cyberonics (NSDQ:CYBX), seeking to prevent Sorin from dodging a $3.76 billion environmental lawsuit filed against its former corporate parent. Sorin and Cyberonics, which announced the merger in February, plan to re-brand the combined company as LivaNova and […]
Abbott has lots of dry powder for medtech M&A
Abbott (NYSE:ABT) CEO Miles White yesterday said the company has a few irons in the fire when it comes to bolstering its flagging medical device business, which was down -6.1% during the 2nd quarter. Despite an attempt to be “studiously evasive” when asked about mergers & acquisitions in general, White spent a good portion of the […]
Medtronic wants $6m for legal fees in Mirowski spat
Medtronic (NYSE:MDT) asked a federal court for a $6 million award to cover its legal costs in the long-running battle with Mirowski Family Ventures involving patents licensed to Boston Scientific (NYSE:BSX). A federal judge in Delaware ruled in June that MFV must cover legal costs in the case, which made it all the way to the U.S. Supreme Court […]
Micell launches MiStent SES trial in China
Micell Technologies said today it launched a Chinese trial of its MiStent SES sirolimus eluting absorbable polymer coronary stent system used to treat coronary artery disease. The prospective, single-blind, multi-center, randomized, controlled Dessolve C trial looks to enroll 428-patients in a study comparing the company’s MiStent SES and the Tivoli bioabsorbable coated stent, which Durham, […]
Boston Scientific wins FDA nod, CE Mark for Safari2 guidewire
Boston Scientific (NYSE:BSX) said today it won FDA 510(k) clearance and CE Mark approval in the European Union for its Safari2 pre-shaped guidewire designed for placing interventional devices in the heart. The Safari2 is specifically intended for use with transcatheter aortic valve implantation or replacement procedures.. Boston Scientific’s new pre-shaped guidewire is compatible with all TAVI/R […]
Thoratec acquisition pushes St. Jude Medical to 52-week high
St. Jude Medical (NYSE:STJ) shares hit a 52-week high yesterday on rumors of the $3.4 billion buyout of Thoratec (NSDQ:THOR) it confirmed today, also reporting a more than 7.4% bottom-line gain for the 2nd quarter and boosted its outlook for the rest of the year. Little Canada, Minn.-based St. Jude posted profits of $290 million, or $1.02 per share, on […]
St. Jude Medical confirms $3.4B Thoratec buyout
St. Jude Medical (NYSE:STJ) and Thoratec (NSDQ:THOR) today confirmed that St. Jude agreed to acquire Thoratec for $3.4 billion. The terms of the deal call for St. Jude to pay $63.50 in cash for each share of Pleasanton, Calif.-based Thoratec, funded using term loans and senior unsecured debt, Little Canada, Minn.-based St. Jude said. Rumors about a possible […]
Biotronik wins FDA nod, launches Itrevia CRT-D in US
Biotronik said today it won FDA premarket approval for its quadripolar Itrevia HF-T cardiac resynchronization defibrillator and launched the device in the U.S. market. The device includes a closed loop stimulation algorithm, capable of adapting heart rate in response to physiological demands independent of movement or respiration, Biotronik said. “The FDA has approved CLS as […]